Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System

about

Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System

Item

http://www.wikidata.org/entity/Q42734907

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparative effectiveness of a ...... Brazilian Public Health System

@en

Comparative effectiveness of a ...... Brazilian Public Health System

@nl

type

Item

label

Comparative effectiveness of a ...... Brazilian Public Health System

@en

Comparative effectiveness of a ...... Brazilian Public Health System

@nl

prefLabel

Comparative effectiveness of a ...... Brazilian Public Health System

@en

Comparative effectiveness of a ...... Brazilian Public Health System

@nl

P1476

Comparative effectiveness of a ...... Brazilian Public Health System

@en

P2093

Alessandra Maciel Almeida

http://www.w3.org/2001/XMLSchema#string

Augusto Afonso Guerra Junior

http://www.w3.org/2001/XMLSchema#string

Brian Godman

http://www.w3.org/2001/XMLSchema#string

Francisco de Assis Acurcio

http://www.w3.org/2001/XMLSchema#string

Haliton Alves de Oliveira Junior

http://www.w3.org/2001/XMLSchema#string

Juliana Alvares

http://www.w3.org/2001/XMLSchema#string

Jéssica Barreto Ribeiro Dos Santos

http://www.w3.org/2001/XMLSchema#string

Marion Bennie

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis

EuroQol--a new facility for the measurement of health-related quality of life

The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Roles of nurse practitioners and physician assistants in rheumatology practices in the US.

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treating rheumatoid arthritis to target: recommendations of an international task force.

P304

539-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CER-2016-0027

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adriana Maria Kakehasi

P577

2016-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27641309

http://www.w3.org/2001/XMLSchema#string

P921

public health

adalimumab

P932

5097454

http://www.w3.org/2001/XMLSchema#string